Systems Modeling of Anti-apoptotic Pathways in Prostate Cancer: Psychological Stress Triggers a Synergism Pattern Switch in Drug Combination Therapy
Open Access
- 5 December 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 9 (12) , e1003358
Abstract
Author Summary Psychological stress and anxiety are often experienced by prostate cancer patients, but the underlying mechanisms of interactions between psychological stress and cancer development, as well as drug resistance, are unclear. Here, we employed a systems biology approach to study interactions between stress-activated epinephrine/beta2 adrenergic receptor/protein kinase A signaling and a regulatory network that controls apoptosis in prostate cancer cells. We developed a dynamic network model of signaling pathways that control apoptosis in prostate cancer cells and quantitatively evaluated the effects of stress-activated signaling on apoptosis induced by drug combinations. Experimental data were used to guide modeling, to fit the unknown parameters and validate the model. Based on our model we found that epinephrine/beta2 adrenergic receptor/protein kinase A signaling can decrease drug efficiency, and can shift the effect of drug combination from synergy to antagonism. We also predicted that in addition to BAD phosphorylation Mcl-1 expression could be upregulated by stress/epinephrine signaling to inhibit apoptosis. This study provides insights into the mechanisms of psychological stress signaling in therapy-resistant cancer, and suggests that reducing psychological stress could help to make prostate cancer treatment more effective.Keywords
This publication has 32 references indexed in Scilit:
- Targeting psychoemotional stress to treat prostate cancerAsian Journal of Andrology, 2013
- Behavioral stress accelerates prostate cancer development in miceJournal of Clinical Investigation, 2013
- Dynamics within the CD95 death‐inducing signaling complex decide life and death of cellsMolecular Systems Biology, 2010
- Synergistic drug combinations tend to improve therapeutically relevant selectivityNature Biotechnology, 2009
- Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesCell Death & Differentiation, 2009
- Design principles of biochemical oscillatorsNature Reviews Molecular Cell Biology, 2008
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and BistabilityPLOS Computational Biology, 2006
- Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapyNature Clinical Practice Oncology, 2006
- The influence of bio-behavioural factors on tumour biology: pathways and mechanismsNature Reviews Cancer, 2006